About
Gene Therapy
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyNorth & South Carolina
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
36
By Phase
PHASE1/PHASE2: 2
By Status
RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT05878860Lead Sponsor
ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis
PHASE1/PHASE2Recruiting
21 participants
Started: Aug 22, 2023 · Completed: Oct 31, 2029
NCT03920007Lead Sponsor
Study of Subretinally Injected ATSN-101 Administered in Patients With Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D
PHASE1/PHASE2Active, not recruiting
15 participants
Started: Sep 12, 2019 · Completed: May 19, 2027
Locations (1)
Headquarters
Durham, NC, United States
Map
Loading map...